Determining Zinc Status in an Inflamed Patient
Measure plasma zinc alongside CRP and albumin simultaneously, and interpret the zinc level only in the context of the inflammatory response—plasma zinc drops significantly when CRP exceeds 20 mg/L due to redistribution rather than true deficiency. 1
The Core Problem with Zinc Assessment During Inflammation
Plasma zinc remains the most widely used test to confirm zinc deficiency, but acute inflammation fundamentally alters its interpretation. During the acute phase response, zinc rapidly redistributes from plasma albumin to the liver where it binds to metallothionein—this happens very quickly, as demonstrated in perioperative studies 1. This redistribution correlates with elevated IL-6, IL-8, and TNF-α levels 1.
Practical Algorithm for Assessment
Step 1: Measure the Right Biomarkers Together
- Plasma zinc (via ICP-MS or atomic absorption spectroscopy)
- CRP (or other acute phase markers like AGP)
- Serum albumin
These three must be measured simultaneously for valid interpretation 1.
Step 2: Interpret Based on CRP Level
If CRP > 20 mg/L:
- Plasma zinc will be artificially low due to redistribution, not true deficiency 1
- Low values normalize with clinical improvement 1
- Consider using the BRINDA adjustment equation (available as an R package) that adjusts serum zinc using CRP or AGP for various populations 1
- Alternatively, consider albumin-corrected zinc, which recent research suggests may accurately estimate "true" zinc levels during infection 2
If CRP < 20 mg/L:
- Plasma zinc can be interpreted more reliably
- Still adjust for albumin changes (0.25 μmol/L decrease in zinc per 1 g/L decrease in albumin) 3
Step 3: Account for Additional Confounders
Temperature: Plasma zinc decreases by approximately 0.59 μmol/L per degree Celsius increase in axillary temperature 3
Dehydration: Paradoxically increases plasma zinc concentrations through hemoconcentration 3
Hemolysis: Increases plasma zinc measurements artificially 3
Alternative Testing Methods (and Why They're Impractical)
Blood cell zinc (neutrophils, lymphocytes, platelets): While these decline more rapidly than plasma zinc during depletion, technical difficulties make hospital measurement impractical 1. Recent research shows RBC zinc and plasma zinc are essentially unrelated in hospitalized patients (correlation coefficient -0.09), possibly because RBC zinc doesn't decrease with acute illness like plasma zinc does 4.
Erythrocyte zinc: Shows little to no change during experimental zinc depletion while plasma zinc falls significantly—making it unreliable 1
Hair zinc: Not used in hospital practice due to contamination issues and interpretation difficulties 1
Critical Pitfalls to Avoid
Don't interpret isolated plasma zinc values during active inflammation—you'll overdiagnose deficiency. Studies show 52% of infected patients appeared zinc deficient by plasma levels, but after albumin correction, all were within normal ranges 2.
Don't ignore timing—serum zinc fluctuates by up to 20% during a 24-hour period due to food ingestion 1. Standardize collection timing when possible.
Don't assume low zinc during inflammation requires supplementation—the redistribution is a physiological response. Research in critically ill patients shows 58% had plasma zinc deficiency at admission, but this reflects redistribution, not necessarily true body zinc depletion 5.
When True Deficiency is Present
Look for clinical features beyond just lab values:
- Severe deficiency: Alopecia, characteristic skin rash (face, groins, hands, feet), impaired wound healing, diarrhea, taste/smell changes 1
- Mild deficiency: Reduced growth rate (in children), impaired immune function 1
The Bottom Line for Clinical Practice
In inflamed patients, plasma zinc alone is unreliable. Either wait for inflammation to resolve and retest, or use albumin-corrected zinc values with BRINDA adjustment equations. The 52% reduction in apparent zinc deficiency after albumin correction in one study 2 demonstrates how misleading raw plasma zinc can be during acute illness. Consider the clinical context—risk factors like malabsorption, increased losses, inadequate intake—alongside adjusted laboratory values rather than treating numbers in isolation.